ReviewTuberculosis (Edinburgh, Scotland)2007
Co-infection with human immunodeficiency virus and tuberculosis in Asia.
Review in Tuberculosis (Edinburgh, Scotland), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Pulmonary Tuberculosis and Risk of Lung Cancer: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2022Review
- Novel polymorphisms inGlobal health, epidemiology and genomics · 2018Article
- A 20-year retrospective cohort study of TB infection among the Hill-tribe HIV/AIDS populations, Thailand.BMC infectious diseases · 2016Review
- [Diagnostic and therapeutic management of lymph node tuberculosis in Tunisia].The Pan African medical journal · 2014Article
- Willingness to use the oral fluid HIV rapid test among men who have sex with men in Beijing, China.PloS one · 2013Article
- Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.BMC microbiology · 2010Article
- Ocular Tuberculosis Initially Presenting as Central Retinal Vein Occlusion.Case reports in ophthalmology · 2010Article
- Simoultaneuos occurence of other diseases among prison inmates with tuberculosis.Current health sciences journal · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Asia has the highest numbers of tuberculosis cases (60% of the global total) and has experienced a marked rise in HIV seroprevalence (22% of the global total) in key subpopulations of these highly populous nations. Thus, co-infected patients are a challenge for practitioners and public health workers alike. The U.S.-Japan Cooperative Medical Science Program is spearheading interdisciplinary collaborations in Asia to address the many outstanding research priorities for HIV-tuberculosis co-infection. There is an urgency to this agenda for many reasons, including the frequency with which tuberculosis accounts for the death of HIV-infected persons in Asia, and the continued rise of multiple drug-resistant Mycobacterium tuberculosis. We review briefly the public health situation in Asia, highlighting research questions from US-Japan-Asian partner joint meetings, and cite salient studies to indicate trends and challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.